Drug Shortage Report for JAMP NEVIRAPINE
Report ID | 162493 |
Drug Identification Number | 02405776 |
Brand name | JAMP NEVIRAPINE |
Common or Proper name | Nevirapine Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | NEVIRAPINE |
Strength(s) | 200MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | J05AG |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-05-31 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-09-02 |
Shortage status | Resolved |
Updated date | 2022-09-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-09-06 | French | Compare |
v7 | 2022-09-06 | English | Compare |
v6 | 2022-08-30 | French | Compare |
v5 | 2022-08-30 | English | Compare |
v4 | 2022-08-02 | French | Compare |
v3 | 2022-08-02 | English | Compare |
v2 | 2022-06-13 | French | Compare |
v1 | 2022-06-13 | English | Compare |
Showing 1 to 8 of 8